Seeing Is Believing
with an average price target of $-26020.97. This is a potential upside of $-26023.95 (-873286.91%) from yesterday's end of day stock price of $2.98.
First Wave BioPharma's activity chart (see below) currently has 9 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 290.5 days.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 05-Apr-2023. First documented stock forecast 17-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
2 years 6 months 3 days ago
(05-Apr-2023)
2/2 (100%)
$-28097.2 (-65.65%)
116
Buy
3 years 1 months 7 days ago
(31-Aug-2022)
2/2 (100%)
$-4174.83 (-16.58%)
100
Hold
$12600
3 years 9 months 28 days ago
(10-Dec-2021)
1/1 (100%)
$-16892.3 (-57.28%)
735
Buy
$33600
$33597.02 (1127416.75%)
6 years 7 months 12 days ago
(26-Feb-2019)
1/1 (100%)
$-54931.46 (-62.05%)
211
What is FWBI (First Wave BioPharma) average time for price targets to be met?
Which analyst has the current highest performing score on FWBI (First Wave BioPharma) with a proven track record?
Which analyst has the current lower performing score on FWBI (First Wave BioPharma) with a proven track record?
Which analyst has the most public recommendations on FWBI (First Wave BioPharma)?
Which analyst is the currently most bullish on FWBI (First Wave BioPharma)?
Which analyst is the currently most reserved on FWBI (First Wave BioPharma)?